Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1987;65(1):1–10.

Immunological aspects of the prevention of viral diseases*

WHO Workshop
PMCID: PMC2490846  PMID: 3495361

Abstract

This article summarizes the conclusions of a WHO Workshop which reviewed the role of immunological mechanisms in protection against and recovery from virus diseases. Antibodies are important for preventing infection from some viruses, e.g., influenza virus. In contrast, cell-mediated immunity is more important in the process of recovery from an already established infection. Furthermore, while antibodies are extremely specific in their action, cell-mediated immunity exhibits a greater degree of cross-reactivity. This finding could be useful in designing potential vaccines, particularly attenuated virus vaccines using molecular biological methods. Such an approach could be valuable for poliomyelitis vaccine, whose RNA sequence has now been determined. The possibility of using recombinant vaccinia viruses as a potential vector for other virus antigens is also discussed.

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aderka D., Novick D., Hahn T., Fischer D. G., Wallach D. Increase of vulnerability to lymphotoxin in cells infected by vesicular stomatitis virus and its further augmentation by interferon. Cell Immunol. 1985 May;92(2):218–225. doi: 10.1016/0008-8749(85)90003-6. [DOI] [PubMed] [Google Scholar]
  2. Almond J. W., Stanway G., Cann A. J., Westrop G. D., Evans D. M., Ferguson M., Minor P. D., Spitz M., Schild G. C. New poliovirus vaccines: a molecular approach. Vaccine. 1984 Sep;2(3):177–184. doi: 10.1016/0264-410x(84)90081-1. [DOI] [PubMed] [Google Scholar]
  3. Arbeter A. M., Starr S. E., Preblud S. R., Ihara T., Paciorek P. M., Miller D. S., Zelson C. M., Proctor E. A., Plotkin S. A. Varicella vaccine trials in healthy children. A summary of comparative and follow-up studies. Am J Dis Child. 1984 May;138(5):434–438. doi: 10.1001/archpedi.1984.02140430012004. [DOI] [PubMed] [Google Scholar]
  4. Askonas B. A., Mullbacher A., Ashman R. B. Cytotoxic T-memory cells in virus infection and the specificity of helper T cells. Immunology. 1982 Jan;45(1):79–84. [PMC free article] [PubMed] [Google Scholar]
  5. Czarniecki C. W., Fennie C. W., Powers D. B., Estell D. A. Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons. J Virol. 1984 Feb;49(2):490–496. doi: 10.1128/jvi.49.2.490-496.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. De Maeyer-Guignard J., De Maeyer E. Immunomodulation by interferons: recent developments. Interferon. 1985;6:69–91. [PubMed] [Google Scholar]
  7. Ennis F. A., Meager A., Beare A. S., Qi Y. H., Riley D., Schwarz G., Schild G. C., Rook A. H. Interferon induction and increased natural killer-cell activity in influenza infections in man. Lancet. 1981 Oct 24;2(8252):891–893. doi: 10.1016/s0140-6736(81)91390-8. [DOI] [PubMed] [Google Scholar]
  8. Ennis F. A., Meager A. Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus. J Exp Med. 1981 Nov 1;154(5):1279–1289. doi: 10.1084/jem.154.5.1279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Evans D. M., Dunn G., Minor P. D., Schild G. C., Cann A. J., Stanway G., Almond J. W., Currey K., Maizel J. V., Jr Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature. 1985 Apr 11;314(6011):548–550. doi: 10.1038/314548a0. [DOI] [PubMed] [Google Scholar]
  10. Evans D. M., Minor P. D., Schild G. S., Almond J. W. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature. 1983 Aug 4;304(5925):459–462. doi: 10.1038/304459a0. [DOI] [PubMed] [Google Scholar]
  11. Ferguson M., Evans D. M., Magrath D. I., Minor P. D., Almond J. W., Schild G. C. Induction by synthetic peptides of broadly reactive, type-specific neutralizing antibody to poliovirus type 3. Virology. 1985 Jun;143(2):505–515. doi: 10.1016/0042-6822(85)90389-7. [DOI] [PubMed] [Google Scholar]
  12. Klatzmann D., Montagnier L. Approaches to AIDS therapy. Nature. 1986 Jan 2;319(6048):10–11. doi: 10.1038/319010a0. [DOI] [PubMed] [Google Scholar]
  13. Kurane I., Binn L. N., Bancroft W. H., Ennis F. A. Human lymphocyte responses to hepatitis A virus-infected cells: interferon production and lysis of infected cells. J Immunol. 1985 Sep;135(3):2140–2144. [PubMed] [Google Scholar]
  14. McMichael A. J., Askonas B. A. Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell. Eur J Immunol. 1978 Oct;8(10):705–711. doi: 10.1002/eji.1830081007. [DOI] [PubMed] [Google Scholar]
  15. McMichael A. J., Michie C. A., Gotch F. M., Smith G. L., Moss B. Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J Gen Virol. 1986 Apr;67(Pt 4):719–726. doi: 10.1099/0022-1317-67-4-719. [DOI] [PubMed] [Google Scholar]
  16. Minor P. D., Schild G. C., Bootman J., Evans D. M., Ferguson M., Reeve P., Spitz M., Stanway G., Cann A. J., Hauptmann R. Location and primary structure of a major antigenic site for poliovirus neutralization. Nature. 1983 Feb 24;301(5902):674–679. doi: 10.1038/301674a0. [DOI] [PubMed] [Google Scholar]
  17. Morris A. G., Lin Y. L., Askonas B. A. Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell. Nature. 1982 Jan 14;295(5845):150–152. doi: 10.1038/295150a0. [DOI] [PubMed] [Google Scholar]
  18. Perussia B., Fanning V., Trinchieri G. A leukocyte subset bearing HLA-DR antigens is responsible for in vitro alpha interferon production in response to viruses. Nat Immun Cell Growth Regul. 1985;4(3):120–137. [PubMed] [Google Scholar]
  19. Plotkin S. A., Smiley M. L., Friedman H. M., Starr S. E., Fleisher G. R., Wlodaver C., Dafoe D. C., Friedman A. D., Grossman R. A., Barker C. F. Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants. Lancet. 1984 Mar 10;1(8376):528–530. doi: 10.1016/s0140-6736(84)90930-9. [DOI] [PubMed] [Google Scholar]
  20. Prince G. A., Hemming V. G., Horswood R. L., Chanock R. M. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Res. 1985 Oct;3(3):193–206. doi: 10.1016/0168-1702(85)90045-0. [DOI] [PubMed] [Google Scholar]
  21. Rook A. H., Smith W. J., Burdick J. F., Manischewitz J. F., Frederick W., Siegel J. P., Williams G. M., Quinnan G. V. Virus-specific cytotoxic lymphocyte responses are predictive of the outcome of cytomegalovirus infection of renal transplant recipients. Transplant Proc. 1984 Dec;16(6):1466–1469. [PubMed] [Google Scholar]
  22. Stott E. J., Taylor G. Respiratory syncytial virus. Brief review. Arch Virol. 1985;84(1-2):1–52. doi: 10.1007/BF01310552. [DOI] [PubMed] [Google Scholar]
  23. Stott E. J., Thomas L. H., Taylor G., Collins A. P., Jebbett J., Crouch S. A comparison of three vaccines against respiratory syncytial virus in calves. J Hyg (Lond) 1984 Oct;93(2):251–261. doi: 10.1017/s0022172400064779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Taylor P. M., Askonas B. A. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo. Immunology. 1986 Jul;58(3):417–420. [PMC free article] [PubMed] [Google Scholar]
  25. Townsend A. R., McMichael A. J. Specificity of cytotoxic T lymphocytes stimulated with influenza virus. Studies in mice and humans. Prog Allergy. 1985;36:10–43. doi: 10.1159/000409860. [DOI] [PubMed] [Google Scholar]
  26. Yamada A., Young J. F., Ennis F. A. Influenza virus subtype-specific cytotoxic T lymphocytes lyse target cells coated with a protein produced in E. coli. J Exp Med. 1985 Nov 1;162(5):1720–1725. doi: 10.1084/jem.162.5.1720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zinkernagel R. M., Hengartner H., Stitz L. On the role of viruses in the evolution of immune responses. Br Med Bull. 1985 Jan;41(1):92–97. doi: 10.1093/oxfordjournals.bmb.a072033. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES